Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.4 - $1.39 $27,720 - $96,327
69,300 Added 64.12%
177,373 $86,000
Q2 2022

Aug 15, 2022

BUY
$0.63 - $1.22 $2,709 - $5,246
4,300 Added 4.14%
108,073 $71,000
Q2 2021

Aug 16, 2021

SELL
$2.94 - $4.75 $800,797 - $1.29 Million
-272,380 Reduced 72.41%
103,773 $401,000
Q1 2021

May 17, 2021

BUY
$3.99 - $5.53 $92,105 - $127,654
23,084 Added 6.54%
376,153 $1.62 Million
Q4 2020

Feb 16, 2021

BUY
$2.99 - $5.79 $22,753 - $44,061
7,610 Added 2.2%
353,069 $1.38 Million
Q3 2020

Nov 10, 2020

BUY
$4.79 - $9.1 $158,611 - $301,328
33,113 Added 10.6%
345,459 $1.7 Million
Q2 2020

Aug 14, 2020

BUY
$3.61 - $11.84 $120,292 - $394,532
33,322 Added 11.94%
312,346 $2.25 Million
Q1 2020

May 11, 2020

BUY
$2.56 - $6.14 $714,301 - $1.71 Million
279,024 New
279,024 $1.17 Million

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $60.1M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.